Lung Cancer Treatment Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 70 pages | ID: L564ED2F7211EN
Market Monitor Global

Abstracts

Lung Cancer Treatment Drugs are durgs used to cure lung cancer.

This report contains market size and forecasts of Lung Cancer Treatment Drugs in global, including the following market information:

Global Lung Cancer Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Lung Cancer Treatment Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Lung Cancer Treatment Drugs companies in 2021 (%)

The global Lung Cancer Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lung Cancer Treatment Drugs include Roche, AstraZeneca, Eli Lilly and Company, Sanofi-Aventis, Pfizer and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lung Cancer Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lung Cancer Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lung Cancer Treatment Drugs Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Targeted Therapies
• Pipeline Drugs

Global Lung Cancer Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lung Cancer Treatment Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Research Institutes
• Diagnostic Centers
• Others

Global Lung Cancer Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lung Cancer Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lung Cancer Treatment Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Lung Cancer Treatment Drugs revenues share in global market, 2021 (%)

Key companies Lung Cancer Treatment Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Lung Cancer Treatment Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• AstraZeneca
• Eli Lilly and Company
• Sanofi-Aventis
• Pfizer
• GlaxoSmithKline

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lung Cancer Treatment Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lung Cancer Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LUNG CANCER TREATMENT DRUGS OVERALL MARKET SIZE

2.1 Global Lung Cancer Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Lung Cancer Treatment Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Lung Cancer Treatment Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Lung Cancer Treatment Drugs Players in Global Market
3.2 Top Global Lung Cancer Treatment Drugs Companies Ranked by Revenue
3.3 Global Lung Cancer Treatment Drugs Revenue by Companies
3.4 Global Lung Cancer Treatment Drugs Sales by Companies
3.5 Global Lung Cancer Treatment Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Lung Cancer Treatment Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Lung Cancer Treatment Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lung Cancer Treatment Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Lung Cancer Treatment Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Lung Cancer Treatment Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Lung Cancer Treatment Drugs Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Targeted Therapies
  4.1.4 Pipeline Drugs
4.2 By Type - Global Lung Cancer Treatment Drugs Revenue & Forecasts
  4.2.1 By Type - Global Lung Cancer Treatment Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Lung Cancer Treatment Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Lung Cancer Treatment Drugs Sales & Forecasts
  4.3.1 By Type - Global Lung Cancer Treatment Drugs Sales, 2017-2022
  4.3.2 By Type - Global Lung Cancer Treatment Drugs Sales, 2023-2028
  4.3.3 By Type - Global Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Lung Cancer Treatment Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lung Cancer Treatment Drugs Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Research Institutes
  5.1.4 Diagnostic Centers
  5.1.5 Others
5.2 By Application - Global Lung Cancer Treatment Drugs Revenue & Forecasts
  5.2.1 By Application - Global Lung Cancer Treatment Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Lung Cancer Treatment Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Lung Cancer Treatment Drugs Sales & Forecasts
  5.3.1 By Application - Global Lung Cancer Treatment Drugs Sales, 2017-2022
  5.3.2 By Application - Global Lung Cancer Treatment Drugs Sales, 2023-2028
  5.3.3 By Application - Global Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Lung Cancer Treatment Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lung Cancer Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Treatment Drugs Revenue & Forecasts
  6.2.1 By Region - Global Lung Cancer Treatment Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Lung Cancer Treatment Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Lung Cancer Treatment Drugs Sales & Forecasts
  6.3.1 By Region - Global Lung Cancer Treatment Drugs Sales, 2017-2022
  6.3.2 By Region - Global Lung Cancer Treatment Drugs Sales, 2023-2028
  6.3.3 By Region - Global Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Lung Cancer Treatment Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Lung Cancer Treatment Drugs Sales, 2017-2028
  6.4.3 US Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.4.4 Canada Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.4.5 Mexico Lung Cancer Treatment Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Lung Cancer Treatment Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Lung Cancer Treatment Drugs Sales, 2017-2028
  6.5.3 Germany Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.5.4 France Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.5.5 U.K. Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.5.6 Italy Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.5.7 Russia Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.5.9 Benelux Lung Cancer Treatment Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Lung Cancer Treatment Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Lung Cancer Treatment Drugs Sales, 2017-2028
  6.6.3 China Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.6.4 Japan Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.6.5 South Korea Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.6.7 India Lung Cancer Treatment Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Lung Cancer Treatment Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Lung Cancer Treatment Drugs Sales, 2017-2028
  6.7.3 Brazil Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.7.4 Argentina Lung Cancer Treatment Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Lung Cancer Treatment Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Lung Cancer Treatment Drugs Sales, 2017-2028
  6.8.3 Turkey Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.8.4 Israel Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Lung Cancer Treatment Drugs Market Size, 2017-2028
  6.8.6 UAE Lung Cancer Treatment Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Lung Cancer Treatment Drugs Major Product Offerings
  7.1.4 Roche Lung Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Roche Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Lung Cancer Treatment Drugs Major Product Offerings
  7.2.4 AstraZeneca Lung Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Eli Lilly and Company
  7.3.1 Eli Lilly and Company Corporate Summary
  7.3.2 Eli Lilly and Company Business Overview
  7.3.3 Eli Lilly and Company Lung Cancer Treatment Drugs Major Product Offerings
  7.3.4 Eli Lilly and Company Lung Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Eli Lilly and Company Key News
7.4 Sanofi-Aventis
  7.4.1 Sanofi-Aventis Corporate Summary
  7.4.2 Sanofi-Aventis Business Overview
  7.4.3 Sanofi-Aventis Lung Cancer Treatment Drugs Major Product Offerings
  7.4.4 Sanofi-Aventis Lung Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Sanofi-Aventis Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Lung Cancer Treatment Drugs Major Product Offerings
  7.5.4 Pfizer Lung Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Pfizer Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Lung Cancer Treatment Drugs Major Product Offerings
  7.6.4 GlaxoSmithKline Lung Cancer Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 GlaxoSmithKline Key News

8 GLOBAL LUNG CANCER TREATMENT DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Lung Cancer Treatment Drugs Production Capacity, 2017-2028
8.2 Lung Cancer Treatment Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Lung Cancer Treatment Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 LUNG CANCER TREATMENT DRUGS SUPPLY CHAIN ANALYSIS

10.1 Lung Cancer Treatment Drugs Industry Value Chain
10.2 Lung Cancer Treatment Drugs Upstream Market
10.3 Lung Cancer Treatment Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Lung Cancer Treatment Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Lung Cancer Treatment Drugs in Global Market
Table 2. Top Lung Cancer Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Lung Cancer Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Lung Cancer Treatment Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Lung Cancer Treatment Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Lung Cancer Treatment Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Lung Cancer Treatment Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Lung Cancer Treatment Drugs Product Type
Table 9. List of Global Tier 1 Lung Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Lung Cancer Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Lung Cancer Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Lung Cancer Treatment Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Lung Cancer Treatment Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Lung Cancer Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Lung Cancer Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Lung Cancer Treatment Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Lung Cancer Treatment Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Lung Cancer Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Lung Cancer Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Lung Cancer Treatment Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Lung Cancer Treatment Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Lung Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Lung Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Lung Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Lung Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Lung Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Lung Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Lung Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Lung Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Lung Cancer Treatment Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Lung Cancer Treatment Drugs Sales, (K Units), 2023-2028
Table 46. Roche Corporate Summary
Table 47. Roche Lung Cancer Treatment Drugs Product Offerings
Table 48. Roche Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Lung Cancer Treatment Drugs Product Offerings
Table 51. AstraZeneca Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Eli Lilly and Company Corporate Summary
Table 53. Eli Lilly and Company Lung Cancer Treatment Drugs Product Offerings
Table 54. Eli Lilly and Company Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sanofi-Aventis Corporate Summary
Table 56. Sanofi-Aventis Lung Cancer Treatment Drugs Product Offerings
Table 57. Sanofi-Aventis Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Lung Cancer Treatment Drugs Product Offerings
Table 60. Pfizer Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. GlaxoSmithKline Corporate Summary
Table 62. GlaxoSmithKline Lung Cancer Treatment Drugs Product Offerings
Table 63. GlaxoSmithKline Lung Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Lung Cancer Treatment Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Lung Cancer Treatment Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Lung Cancer Treatment Drugs Production by Region, 2017-2022 (K Units)
Table 67. Global Lung Cancer Treatment Drugs Production by Region, 2023-2028 (K Units)
Table 68. Lung Cancer Treatment Drugs Market Opportunities & Trends in Global Market
Table 69. Lung Cancer Treatment Drugs Market Drivers in Global Market
Table 70. Lung Cancer Treatment Drugs Market Restraints in Global Market
Table 71. Lung Cancer Treatment Drugs Raw Materials
Table 72. Lung Cancer Treatment Drugs Raw Materials Suppliers in Global Market
Table 73. Typical Lung Cancer Treatment Drugs Downstream
Table 74. Lung Cancer Treatment Drugs Downstream Clients in Global Market
Table 75. Lung Cancer Treatment Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Lung Cancer Treatment Drugs Segment by Type
Figure 2. Lung Cancer Treatment Drugs Segment by Application
Figure 3. Global Lung Cancer Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Lung Cancer Treatment Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Lung Cancer Treatment Drugs Revenue in 2021
Figure 9. By Type - Global Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Lung Cancer Treatment Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Lung Cancer Treatment Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 19. US Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 24. Germany Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 33. China Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Lung Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Lung Cancer Treatment Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Lung Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Lung Cancer Treatment Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Lung Cancer Treatment Drugs by Region, 2021 VS 2028
Figure 50. Lung Cancer Treatment Drugs Industry Value Chain
Figure 51. Marketing Channels